You
Build the deck described below in our editorial system. Steal compositions from the reference deck; do not copy verbatim.
# Pitch brief — International Vitamin Corporation (IVC)
## Thesis
IVC has built one of the most capable private-label manufacturing platforms in North America, but *the consumer credibility gap between what is on the label and what can be verified* is now costing real shelf velocity across eye health, weight management, energy, and healthy aging. OmniActive's portfolio of clinically studied, named branded ingredients — Lutemax 2020, Capsimax, enXtra, and Zenroot — is designed to close that gap with *drop-in compatible, RCT-backed actives that give retail buyers and end consumers something they can look up and trust*. This is not a supplier pitch; it is a proposal to build a formulation partnership that compounds IVC's scale advantage with the one asset scale alone cannot manufacture: *scientific credibility that survives a Google search*.
Lead with: "The supplement shopper in 2025 opens Amazon, Reddit, and ConsumerLab before they open their wallet — and *IVC's best categories are one ingredient upgrade away from winning that moment*."
## Target snapshot
- Positioning: IVC positions itself as one of the largest contract manufacturers and private-label suppliers of vitamins, minerals, supplements, and OTC health products in North America, serving mass-market retailers, club stores, and specialty health channels. They emphasize scale, speed-to-market, and cost efficiency as core competitive advantages over branded ingredient peers.
- Primary category: Contract manufacturing and private-label VMS across full-spectrum consumer health
- Relevant product lines: Multivitamins (adult, senior, prenatal, children's), Eye health supplements, Immunity support (Vitamin C, Zinc, Elderberry combinations), Energy and metabolism (B-vitamins, CoQ10, adaptogens), Healthy aging / antioxidant formulas, Sleep support (Melatonin-based and botanical blends), Sports nutrition and protein supplements, Omega / fish oil softgels, Weight management formulas, Condition-specific OTC-adjacent supplements (joint, heart, brain)
- Why us: OmniActive's portfolio of clinically studied, branded ingredients — particularly Lutemax 2020 (eye and cognitive health), Capsimax (weight management and metabolism), and OmniXan/carotenoid actives (antioxidant and healthy aging) — directly addresses IVC's need to elevate private-label formulas beyond commodity status with science-backed, on-pack-claimable differentiation. As a manufacturer serving retailers who increasingly demand clinical substantiation and clean-label credibility, IVC gains a meaningful competitive moat by embedding recognized branded ingredients that consumers and buyers can verify independently. A partnership framing — where OmniActive supports IVC with formulation guidance, clinical dossiers, and co-marketing assets — aligns with IVC's speed-to-market model while reducing their internal R&D burden.
## Approved consumer pains
- (iherb · high) Healthy Aging / Antioxidant Formulas — Generic antioxidant blends feel undifferentiated: ""This is just the same vitamin C and E combo I can get anywhere. I was hoping for something more targeted for aging — this feels like a basic multivitamin repackaged.""
- (reddit · med) Healthy Aging / Antioxidant Formulas — Lack of cognitive health angle in formula: ""I'm 58 and I care just as much about keeping my mind sharp as my joints. Why do none of these 'healthy aging' supplements even mention brain health? It's all just resveratrol and CoQ10.""
- (consumerlab · med) Healthy Aging / Antioxidant Formulas — Poor bioavailability of carotenoid ingredients: ""ConsumerLab tested a bunch of these and the actual carotenoid content was all over the place. I don't trust that what's on the label is what's in the pill with these store brands.""
## Approved opportunities
1. IVC Healthy Aging, *extended into brain and body longevity* (Lutemax 2020, enXtra) — Closes the cognitive health blind spot and generic antioxidant-blend fatigue in IVC's healthy aging line by pairing Lutemax 2020's macular and systemic carotenoid antioxidant story with enXtra's acute, RCT-backed caffeine-free cognitive focus benefit — creating a differentiated 'body and mind' aging formula no commodity vitamin C/E blend can replicate. · leverage 8/10, feasibility 8/10
Feasibility notes: Both ingredients are compatible in a single capsule or softgel format with no known interaction concerns; enXtra's GRAS status and Lutemax 2020's established regulatory dossier mean IVC faces minimal new regulatory work, though the dual-ingredient cognitive-plus-eye narrative will require coordinated marketing investment to land clearly with consumers.
Revenue read: low-double-digit revenue lift on the healthy aging franchise within 18-24 months, with line-extension potential into a dedicated brain health SKU as a second phase
## Evidence to feature
### Lutemax 2020
- Lutein and zeaxanthin from Lutemax 2020 function as both macular-specific antioxidants and systemic carotenoid antioxidants, providing a targeted, tissue-specific antioxidant mechanism that is categorically distinct from the generic vitamin C/E/selenium blends consumers find interchangeable. → Beyond eye health, published research on Lutemax 2020 demonstrates cognitive and stress-reduction benefits (LAMA study: improved sleep quality, visual processing, and brain-derived neurotrophic factor markers), giving IVC a multi-benefit 'healthy aging' story built around a single named ingredient.
- Lutemax 2020 delivers carotenoids in a naturally occurring marigold-derived matrix that includes co-occurring lipid fractions and saponification-optimized free and esterified forms, supporting efficient micellarization and intestinal absorption compared to synthetic or isolated carotenoid powders. → Pharmacokinetic studies on Lutemax 2020 confirm dose-dependent increases in plasma lutein and zeaxanthin concentrations, and ConsumerLab-style third-party verification of branded ingredients like Lutemax 2020 consistently shows label-accurate carotenoid content — directly countering the ConsumerLab variability concern consumers cite.
### enXtra
- enXtra (Alpinia galanga extract) modulates alpha brain wave activity and supports acetylcholine-related pathways to deliver caffeine-free, acute cognitive focus and mental clarity — adding a direct brain health dimension to a formula that currently addresses only cellular or physical aging. → Multiple acute RCTs on enXtra demonstrate statistically significant improvements in attention, focus, and alertness within one hour of a single dose, with effects sustained for up to five hours — providing IVC with a fast-onset, clinically measurable cognitive claim for a healthy aging label.
## Pitch arc
01 — Title — The Partnership Bet: Establish OmniActive and IVC as aligned builders — two ingredient-serious companies with a shared opportunity to move IVC's best-selling categories from commodity to clinically credible.
02 — Why Now — The Credibility Inflection: Show that the supplement consumer has structurally shifted: Reddit threads, Amazon reviews, and ConsumerLab audits now punish vague label language and reward named, dosed, published ingredients — making 2025 the highest-leverage moment for IVC to upgrade its formulation story.
03 — The Consumer Verdict — What Reviews Actually Say: Surface verbatim consumer pain from Reddit, Amazon, and iHerb reviews across IVC's eye health, weight management, energy, and aging SKUs — translating scattered complaints into a single diagnosis: shoppers are churning because they cannot verify what they are buying.
04 — The Market Signal — Where the Money Is Moving: Quantify the revenue at risk and the revenue available — showing that stimulant-free weight management, macular eye health, clean energy, and brain-body aging are the four fastest-compounding segments, and that IVC's current formulations are positioned behind the curve in each.
05 — The Bridge — How OmniActive Ingredients Work: Explain the mechanism logic behind the four hero ingredients — Lutemax 2020's full macular trio, Capsimax's OmniBead encapsulation, enXtra's non-stimulant alertness pathway, and Zenroot's root-only withanolide standardization — in plain language that connects science to shelf story.
06 — Opportunity One — Eye Health and Healthy Aging Upgrades: Present the Lutemax 2020 eye health upgrade and the Lutemax 2020 + enXtra healthy aging extension as paired concept mockups, showing exactly how IVC's existing SKUs would look and read differently — and why that difference closes the comparison-shopping loop for consumers.
07 — Opportunity Two — Stimulant-Free Weight and Clean Energy: Present the Capsimax thermogenic repositioning and the enXtra + Zenroot clean energy rebuild as a second pair of concept mockups, making the case that IVC can own the stimulant-free shelf space in both categories before a competitor does.
08 — The Evidence Stack — RCTs, Doses, and the Comparison Table: Lay out the published human RCT evidence for each ingredient side by side against the generic alternatives IVC currently uses — standardized extract vs. anonymous complex, encapsulated vs. unencapsulated, root-only vs. whole-plant — so the clinical and commercial superiority is undeniable.
09 — Risks and Objections — Addressed Honestly: Acknowledge the real friction points — reformulation cost, label transition timelines, consumer education investment, and price-per-unit delta — and show specifically how OmniActive's regulatory dossiers, drop-in compatibility, and co-marketing support neutralize each one.
10 — The Ask — A Phased Partnership Roadmap: Close with a concrete, low-risk entry proposal: a phased pilot starting with the highest-leverage, most feasible SKU pair, a shared success metric framework, and an invitation to co-develop the 18-month roadmap together — framing the next step as a conversation, not a transaction.
Claude
Generated 10-slide deck — "OmniActive × IVC — Partnership Deck". Preview on the right.